Regencell Bioscience Holdings (Regencell Bioscience Holdings) Price-to-Operating-Cash-Flow

: (As of Today)

View and export this data going back to 2021. Start your Free Trial

As of today (2024-04-18), Regencell Bioscience Holdings's share price is $5.22. Regencell Bioscience Holdings's Cash Flow from Operations per share for the trailing twelve months (TTM) ended in Jun. 2023 was $0.00. Hence, Regencell Bioscience Holdings's Price-to-Operating-Cash-Flow Ratio for today is .

The historical rank and industry rank for Regencell Bioscience Holdings's Price-to-Operating-Cash-Flow or its related term are showing as below:

RGC's Price-to-Operating-Cash-Flow is not ranked ^*
in the Drug Manufacturers industry.
Industry Median: 17.28
* Ranked among companies with meaningful Price-to-Operating-Cash-Flow only.

Regencell Bioscience Holdings's Cash Flow from Operations per share for the six months ended in Jun. 2023 was $0.00. Its Cash Flow from Operations per share for the trailing twelve months (TTM) ended in Jun. 2023 was $0.00.

During the past 3 years, the average Operating Cash Flow per Share Growth Rate was -87.30% per year.

During the past 5 years, Regencell Bioscience Holdings's highest 3-Year average Operating Cash Flow per Share Growth Rate was -87.30% per year. The lowest was -136.70% per year. And the median was -112.00% per year.

Regencell Bioscience Holdings Price-to-Operating-Cash-Flow Historical Data

The historical data trend for Regencell Bioscience Holdings's Price-to-Operating-Cash-Flow can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Regencell Bioscience Holdings Annual Data

Trend

Jun19

Jun20

Jun21

Jun22

Jun23

Price-to-Operating-Cash-Flow

Regencell Bioscience Holdings Semi-Annual Data
	Jun19	Dec19	Jun20	Dec20	Jun21	Dec21	Jun22	Dec22	Jun23
Price-to-Operating-Cash-Flow					-	-	-	-	-

Competitive Comparison

For the Drug Manufacturers - Specialty & Generic subindustry, Regencell Bioscience Holdings's Price-to-Operating-Cash-Flow, along with its competitors' market caps and Price-to-Operating-Cash-Flow data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Regencell Bioscience Holdings Price-to-Operating-Cash-Flow Distribution

For the Drug Manufacturers industry and Healthcare sector, Regencell Bioscience Holdings's Price-to-Operating-Cash-Flow distribution charts can be found below:

* The bar in red indicates where Regencell Bioscience Holdings's Price-to-Operating-Cash-Flow falls into.

Regencell Bioscience Holdings Price-to-Operating-Cash-Flow Calculation

Regencell Bioscience Holdings's Price-to-Operating-Cash-Flow ratio for today is calculated as

Price-to-Operating-Cash-Flow Ratio	=	Share Price	/	Cash Flow from Operations per share (TTM)
	=	5.22	/	0
	=

Regencell Bioscience Holdings's Share Price of today is $5.22.
For company reported semi-annually, GuruFocus uses latest annual data as the TTM data. Regencell Bioscience Holdings's Cash Flow from Operations per share for the trailing twelve months (TTM) ended in Jun. 2023 was $0.00.

Note: Cash Flow from Operations per share is calculated as Cash Flow from Operations divided by Shares Outstanding (Diluted Average).

It can also be calculated from the numbers for the whole company:

Price-to-Operating-Cash-Flow Ratio

Market Cap

Cash Flow from Operations

Regencell Bioscience Holdings Price-to-Operating-Cash-Flow Related Terms

Thank you for viewing the detailed overview of Regencell Bioscience Holdings's Price-to-Operating-Cash-Flow provided by GuruFocus.com. Please click on the following links to see related term pages.

Regencell Bioscience Holdings (Regencell Bioscience Holdings) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Regencell Bioscience Holdings Ltd (NAS:RGC) » Definitions » Price-to-Operating-Cash-Flow

Comparable Companies

Traded in Other Exchanges

N/A

Address

29 Leighton Road, 9/F Chinachem Leighton Plaza, Causeway Bay, Hong Kong, HKG

Website

https://www.regencellbioscience.com

Regencell Bioscience Holdings Ltd is engaged in the research, development and commercialization of traditional Chinese medicine. The medicines are used for the treatment of neurocognitive disorders and degeneration.